| Ytd | -34.37% | |
| 1y | 44.09% |
| Open | 3.23 | Prev Close | 3.25 | Low | 3.10 | High | 3.27 | Mkt Cap | 338.14M |
| Vol | 1.89M | Avg Vol | 1.33M | EPS | -0.91 | P/E | N/A | Forward P/E | -0.19 |
| Beta | 0.51 | Short Ratio | 4.52 | Inst. Own | 46.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 4.42 | 200-d Avg | 5.45 | 1yr Est | 0.87 |
I can sit through a biotech presentation and come away convinced that the company has discovered the
Relmada Therapeutics, Inc. (NASDAQ: RLMD - Get Free Report) has earned an average recommendation of
Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market
Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 49.2% to $7.91 during Friday's pre-